Department of Health, Medicine, and Caring Sciences, Linkoping University Faculty of Medicine, Linkoping, Sweden
Department of Public Health and Clinical Science, Umeå University, Umeå, Sweden.
J Neurointerv Surg. 2024 Jan 12;16(2):156-162. doi: 10.1136/jnis-2023-020299.
Despite the proven cost effectiveness of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) due to large vessel occlusion, treatment within 6 hours from symptom onset remains inaccessible for many patients. We aimed to find the optimal number and location of treatment facilities with respect to the cost effectiveness of MT in patients with AIS, first by the most cost effective implementation of comprehensive stroke centers (CSCs), and second by the most cost effective addition of complementary thrombectomy capable stroke centers (TSCs).
This study was based on nationwide observational data comprising 18 793 patients with suspected AIS potentially eligible for treatment with MT. The most cost effective solutions were attained by solving the p median facility location-allocation problem with the objective function of maximizing the incremental net monetary benefit (INMB) of MT compared with no MT in patients with AIS. Deterministic sensitivity analysis (DSA) was used as the basis of the results analysis.
The implementation strategy with seven CSCs produced the highest annual INMB per patient of all possible solutions in the base case scenario. The most cost effective implementation strategy of the extended scenario comprised seven CSCs and four TSCs. DSA revealed sensitivity to variability in MT rate and the maximum willingness to pay per quality adjusted life year gained.
The combination of optimization modeling and cost effectiveness analysis provides a powerful tool for configuring the extent and locations of CSCs (and TSCs). The most cost effective implementation of CSCs in Sweden entails 24/7 MT services at all seven university hospitals.
尽管机械取栓 (MT) 在因大血管闭塞而导致的急性缺血性脑卒中 (AIS) 患者中已被证明具有成本效益,但由于发病后 6 小时内的治疗仍然无法为许多患者提供。我们旨在根据 AIS 患者 MT 的成本效益,找到具有最佳数量和位置的治疗设施,首先是通过最具成本效益的综合性卒中中心 (CSC) 的实施,其次是通过最具成本效益的补充性取栓能力卒中中心 (TSC) 的添加。
本研究基于包括 18793 例疑似 AIS 患者的全国性观察性数据,这些患者有接受 MT 治疗的潜在可能。通过解决具有最大化 MT 与无 MT 相比的增量净货币效益 (INMB) 的目标函数的 p 中位数设施位置-分配问题,得出了最具成本效益的解决方案。确定性敏感性分析 (DSA) 被用作结果分析的基础。
在基本情况下,七个 CSC 的实施策略产生了所有可能解决方案中每个患者的最高年度 INMB。扩展情况下最具成本效益的实施策略包括七个 CSCs 和四个 TSCs。DSA 显示出对 MT 率和每获得一个质量调整生命年的最大意愿支付的可变性的敏感性。
优化建模和成本效益分析的结合为配置 CSC(和 TSC)的范围和位置提供了一个强大的工具。在瑞典,最具成本效益的 CSC 实施需要在所有七所大学医院提供 24/7 的 MT 服务。